Indrayani Biotech Ltd — Others, 05-04-2025: Compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2025

Indrayani Biotech Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. A confirmation certificate from MUFG Intime India, the company's Registrar and Transfer Agent, verifies that securities were duly received, processed for dematerialization, and listed correctly on the stock exchanges. This careful management of securities reflects the company’s commitment to corporate governance and operational efficiency.

Investors may view this as a positive outlook, as it underscores strong compliance and streamlined operations, contributing to shareholder confidence and potential investment stability.